Kelonia Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Kelonia Therapeutics's estimated annual revenue is currently $4.9M per year.
- Kelonia Therapeutics's estimated revenue per employee is $77,500
Employee Data
- Kelonia Therapeutics has 63 Employees.
- Kelonia Therapeutics grew their employee count by 24% last year.
Kelonia Therapeutics's People
| Name | Title | Email/Phone |
|---|
Kelonia Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Kelonia Therapeutics?
Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.
keywords:N/A
N/A
Total Funding
63
Number of Employees
$4.9M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.9M | 63 | 3% | $63.2M |
#2 | $7.4M | 63 | -7% | N/A |
#3 | $15.3M | 63 | 7% | N/A |
#4 | $9.1M | 63 | -30% | N/A |
#5 | $7.9M | 63 | -9% | $2.6M |